PTO Proposed Rule Could Force Drug Firms To File More Patent Applications
Executive Summary
Biotech and pharmaceutical companies may have to spend more time and money to patent their inventions under a new regulation proposed by the Patent and Trademark Office
You may also be interested in...
New Patent Rules May Hurt Biotech Industry; Limits Set On Certain Filings
The U.S. Patent and Trademark Office is implementing new rules on patent filings that will make it tougher for biotechnology companies to protect their inventions
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.